Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
J David MosinskiAli AminianChristopher L AxelrodEsam BatayyahHector Romero-TalamasChristopher DaigleAnny MulyaAmanda ScelsiPhilip R SchauerStacy A BrethauerJohn P KirwanPublished in: American journal of physiology. Endocrinology and metabolism (2021)
Reductions in β-cell number and function contribute to the onset type 2 diabetes (T2D). Roux-en-Y gastric bypass (RYGB) surgery can resolve T2D within days of operation, indicating a weight-independent mechanism of glycemic control. We hypothesized that RYGB normalizes glucose homeostasis by restoring β-cell structure and function. Male Zucker Diabetic Fatty (fa/fa; ZDF) rats were randomized to sham surgery (n = 16), RYGB surgery (n = 16), or pair feeding (n = 16). Age-matched lean (fa/+) rats (n = 8) were included as a secondary control. Postprandial metabolism was assessed by oral glucose tolerance testing before and 27 days after surgery. Fasting and postprandial plasma GLP-1 was determined by mixed meal tolerance testing. Fasting plasma glucagon was also measured. β-cell function was determined in isolated islets by a glucose-stimulated insulin secretion assay. Insulin and glucagon positive areas were evaluated in pancreatic sections by immunohistochemistry. RYGB reduced body weight (P < 0.05) and improved glucose tolerance (P < 0.05) compared with sham surgery. RYGB reduced fasting glucose compared with both sham (P < 0.01) and pair-fed controls (P < 0.01). Postprandial GLP-1 (P < 0.05) was elevated after RYGB compared with sham surgery. RYGB islets stimulated with 20 mM glucose had higher insulin secretion than both sham and pair-fed controls (P < 0.01) and did not differ from lean controls. Insulin content was greater after RYGB compared with the sham (P < 0.05) and pair-fed (P < 0.05) controls. RYGB improves insulin secretion and pancreatic islet function, which may contribute to the remission of type 2 diabetes following bariatric surgery.NEW & NOTEWORTHY The onset and progression of type 2 diabetes (T2D) results from failure to secrete sufficient amounts of insulin to overcome peripheral insulin resistance. Here, we demonstrate that Roux-en-Y gastric bypass (RYGB) restores islet function and morphology compared to sham and pair-fed controls in ZDF rats. The improvements in islet function were largely attributable to enhanced insulin content and secretory function in response to glucose stimulation.
Keyphrases
- roux en y gastric bypass
- glycemic control
- blood glucose
- weight loss
- type diabetes
- bariatric surgery
- gastric bypass
- obese patients
- minimally invasive
- body weight
- insulin resistance
- double blind
- coronary artery bypass
- surgical site infection
- cardiovascular disease
- single cell
- randomized controlled trial
- adipose tissue
- stem cells
- bone mineral density
- acute coronary syndrome
- bone marrow
- metabolic syndrome
- atrial fibrillation
- skeletal muscle
- polycystic ovary syndrome
- body composition
- rheumatoid arthritis
- coronary artery disease
- cell therapy
- open label